Research
Hormonal
Dual-agonist and tri-agonist administration generally result in greater weight loss compared to GLP-1R agonists used alone.
Practitioners may consider dual- and tri-agonist therapies for enhanced weight loss in patients.
StrongSupportsmedium confidence
Dual-agonist (GLP-1/GIP and GLP-1/GCG) and tri-agonist (GLP-1/GIP/GCG) administration generally result in greater weight loss...
Why this rating
The abstract discusses both preclinical and clinical studies.
Source
Synergistic Combinations of Gut- and Pancreas-Hormone-Based Therapies: Advancements in Treatments for Metabolic Diseases
Sulayman A. Lyons et al. · Endocrinology · 2023
reviewCited 13×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →